Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Smith Hunter C
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-02-11
Sale
2022-02-15
7:31 pm
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
833 $6.1 $5,081 47,192
(Direct)
View
2022-06-30
Sale
2022-07-06
6:08 pm
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
7,547 $4.08 $30,792 57,614
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-12-31
Option Award
2018-01-03
4:20 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
361 $78.72 7,496
(Direct)
View
2018-02-14
Option Award
2018-02-16
4:03 pm
N/A
2028-02-13
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
61,000 $0 61,000
(Direct)
View
2018-03-31
Option Award
2018-04-03
5:00 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
298 $70.14 7,794
(Direct)
View
2018-05-23
Option Award
2018-05-25
1:55 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
1,301 $0 9,095
(Direct)
View
2018-06-30
Option Award
2018-07-03
4:21 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
229 $80.48 9,324
(Direct)
View
2018-09-05
Exercise
2018-09-06
4:02 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
3,000 $6.88 201,744
(Direct)
View
2018-09-05
Exercise
2018-09-06
4:02 pm
N/A
2027-08-08
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
3,000 $0 201,744
(Direct)
View
2018-09-30
Option Award
2018-10-02
5:12 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
249 $91.61 9,573
(Direct)
View
2018-12-31
Option Award
2019-01-03
4:52 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
326 $73.8 9,899
(Direct)
View
2019-01-31
Exercise
2019-02-04
4:01 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
3,000 $6.88 201,744
(Direct)
View
2019-01-31
Exercise
2019-02-04
4:01 pm
N/A
2027-08-08
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
3,000 $0 201,744
(Direct)
View
2019-02-13
Option Award
2019-02-15
4:10 pm
N/A
2029-02-12
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
70,000 $0 70,000
(Direct)
View
2019-03-31
Option Award
2019-04-02
5:11 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
291 $86.88 10,190
(Direct)
View
2019-05-22
Option Award
2019-05-24
5:22 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
1,161 $86.07 11,351
(Direct)
View
2019-06-30
Option Award
2019-07-02
4:26 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
307 $98.57 11,658
(Direct)
View
2019-07-11
Exercise
2019-07-15
4:01 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
10,000 $6.88 201,744
(Direct)
View
2019-07-11
Exercise
2019-07-15
4:01 pm
N/A
2027-08-08
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
10,000 $0 201,744
(Direct)
View
2019-09-30
Option Award
2019-10-02
5:44 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
166 $110.67 11,824
(Direct)
View
2019-12-30
Disposition
2019-12-30
4:47 pm
N/A
N/A
GENESEE & WYOMING INC GWR Smith Hunter C
Director
11,824 $112 0
(Direct)
View
2020-01-28
Exercise
2020-01-29
4:00 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
6,250 $6.88 201,744
(Direct)
View
2020-01-28
Exercise
2020-01-29
4:00 pm
N/A
2027-08-08
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
6,250 $0 201,744
(Direct)
View
2020-02-14
Option Award
2020-02-19
4:23 pm
N/A
2030-02-13
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
82,000 $0 82,000
(Direct)
View
2020-03-13
Exercise
2020-03-16
4:16 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
3,500 $6.88 201,744
(Direct)
View
2020-03-13
Exercise
2020-03-16
4:16 pm
N/A
2027-08-08
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
3,500 $0 201,744
(Direct)
View
2020-03-30
Exercise
2020-03-31
6:00 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
CEO
3,900 $6.88 201,744
(Direct)
View
2020-03-30
Exercise
2020-03-31
6:00 pm
N/A
2027-08-08
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
CEO
3,900 $0 201,744
(Direct)
View
2020-06-30
Option Award
2020-07-02
4:05 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
CEO
25,000 $0 25,000
(Direct)
View
2020-07-20
Option Award
2020-07-21
5:16 pm
N/A
2030-07-19
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
25,000 $0 25,000
(Direct)
View
2021-01-19
Exercise
2021-01-20
4:05 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
4,000 $6.88 201,744
(Direct)
View
2021-01-19
Exercise
2021-01-20
4:05 pm
N/A
2027-08-08
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
4,000 $0 201,744
(Direct)
View
2021-02-11
Option Award
2021-02-16
5:27 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
65,625 $0 65,625
(Direct)
View
2021-04-21
Exercise
2021-04-23
06:08 am
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
5,000 $6.88 201,744
(Direct)
View
2021-04-21
Exercise
2021-04-23
06:08 am
N/A
2027-08-08
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
5,000 $0 201,744
(Direct)
View
2021-11-12
Option Award
2021-11-16
4:34 pm
N/A
2031-11-11
Aeglea BioTherapeutics Inc. AGLE Smith Hunter C
Director
60,000 $0 60,000
(Direct)
View
2022-02-09
Option Award
2022-02-11
9:35 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
113,750 $0 113,750
(Direct)
View
2022-02-11
Exercise
2022-02-15
7:31 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
2,344 $0 47,192
(Direct)
View
2022-06-07
Option Award
2022-06-09
9:19 pm
N/A
2032-06-06
Aeglea BioTherapeutics Inc. AGLE Smith Hunter C
Director
43,000 $0 43,000
(Direct)
View
2022-06-30
Exercise
2022-07-06
6:08 pm
N/A
N/A
RHYTHM PHARMACEUTICALS Inc RYTM Smith Hunter C
CFO
25,000 $0 57,614
(Direct)
View